StonvexLoading…
StonvexStonvexStonvexCore line items from ELMD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $54.36M | $35.78M | $16.89M | $64.00M |
Operating Income | $10.06M | $6.29M | $2.67M | $9.66M |
Net Income | $7.90M | $2.76M | $2.14M | $7.54M |
EPS (Diluted) | $0.91 | $0.56 | $0.25 | $0.85 |
Total Assets | $59.47M | $54.91M | $53.61M | $53.80M |
Total Liabilities | $10.31M | $9.47M | $8.87M | $10.59M |
Cash & Equivalents | $16.98M | $13.79M | $14.11M | $15.29M |
Free Cash Flow OCF − CapEx | $5.64M | $2.31M | $-83.00K | $11.13M |
Shares Outstanding | 8.28M | 8.28M | 8.36M | 8.35M |